Low-molecular-weight chondroitin sulfate attenuates hyperalgesia via immunomodulation of macrophage polarization
Journal of Pharmacological Sciences · 2026-10 · 162 (2) · 109-116
DOI: 10.1016/j.jphs.2026.07.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacological Sciences, 2026-10. Verfasst von Ribou Shiga und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan. Hauptthemen laut MEDLINE: Chondroitin Sulfates, Hyperalgesia, Macrophages, Immunomodulation. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ROHTO Pharmaceutical, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Osteoarthritis is the most common form of arthritis, for which effective and safer treatments are needed. While chondroitin sulfate (CS) has been reported to exert analgesic effects, its cellular targets and immunomodulatory mechanisms remain unclear. This study aimed to clarify the effects of low-molecular-weight CS-rich extract (LMW-CSE) derived from shark cartilage on the hyperalgesia observed in adjuvant-induced arthritis (AIA) mice and to investigate the role of peripheral macrophage (MΦ) subsets in its analgesic action. LMW-CSE was orally administered to mice at doses up to 300 mg/kg twice daily, starting 14 days before AIA with an injection of complete Freund's adjuvant (CFA), and continuing until the completion of behavioral testing. LMW-CSE significantly attenuated hyperalgesia in AIA mice. In addition, the increase in the number of activated excitatory neurons in the spinal superficial dorsal horn of AIA mice was attenuated by LMW-CSE treatment. Flow cytometric analysis revealed that LMW-CSE suppressed the accumulation of proinflammatory M1 MΦs and increased the proportion of immunoregulatory M2 MΦs at inflammatory sites, accompanied by reduced expression of proinflammatory cytokines. These findings suggest that LMW-CSE exerts anti-hyperalgesic effects, at least in part through modulation of peripheral macrophage subsets, supporting its potential as a therapeutic strategy for inflammatory pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
- Regulatory Affairs Promotion Division, ROHTO Pharmaceutical Co., Ltd., Osaka, Japan.
- Division of Pathophysiology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
- Internal Medicine and Functional Food Development Division, ROHTO Pharmaceutical Co., Ltd., Osaka, Japan.
- Quality Design Center, ROHTO Pharmaceutical Co., Ltd., Osaka, Japan.
- Division of Public Health, Hygiene and Epidemiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Senda…
Förderung
- ROHTO Pharmaceutical
- Japan Society for the Promotion of Science
Zitieren
APA
Shiga, R., Yamada, K., Kawano, T., Nakagawasai, O., Seo, Y., Ogura, C., Kubo, O., Miki, Y., Tamada, U., Satoh, M., Takahashi, T., Tan-No, K., & Nemoto, W. (2026). Low-molecular-weight chondroitin sulfate attenuates hyperalgesia via immunomodulation of macrophage polarization. Journal of Pharmacological Sciences, 162(2), 109-116. https://doi.org/10.1016/j.jphs.2026.07.003
Vancouver
Shiga R, Yamada K, Kawano T, Nakagawasai O, Seo Y, Ogura C, et al. Low-molecular-weight chondroitin sulfate attenuates hyperalgesia via immunomodulation of macrophage polarization. Journal of Pharmacological Sciences. 2026;162(2):109-116. doi:10.1016/j.jphs.2026.07.003
BibTeX
@article{Shiga2026,
author = {Shiga, Ribou and Yamada, Kotaro and Kawano, Tasuku and Nakagawasai, Osamu and Seo, Yukari and Ogura, Chiaki and Kubo, Ozora and Miki, Yusuke and Tamada, Uyu and Satoh, Michihiro and Takahashi, Tomoko and Tan-No, Koichi and Nemoto, Wataru},
title = {Low-molecular-weight chondroitin sulfate attenuates hyperalgesia via immunomodulation of macrophage polarization},
journal = {Journal of Pharmacological Sciences},
year = {2026},
volume = {162},
number = {2},
pages = {109--116},
doi = {10.1016/j.jphs.2026.07.003}
}
EUVIMED